Transcripts
Revolution Medicines (RVMD) earnings call transcripts
Earnings call transcripts for Revolution Medicines, Inc., with a summary, the guidance given, and what analysts pressed on.
- Q2 2026 earnings call
Management framed 2026 as a pivotal year, pairing pancreatic launch preparation with broad RAS-inhibitor development while keeping treatment strategies open.
Aug 05, 2026Confident0.78